Skip to main content

Denali Therapeutics Inc.

DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001714899

In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Denali Therapeutics Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of DNLI: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders2172224+9
Shares126.8M69.5K127.9M+1.24M (+1.0%)
Value$3.69B$1.89M$2.61B−$1.08B (−29.3%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (41)

Institutions that held Denali Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to DNLI in Q4 2024
InstitutionSharesValue% of portfolio
Qube Research & Technologies Ltd311,507$6.35M0.01%
Segall Bryant & Hamill, LLC289,075$5.89M0.08%
Twinbeech Capital LP254,586$5.19M0.09%
Susquehanna Fundamental Investments, LLC192,563$3.92M0.07%
Woodline Partners LP100,000$2.04M0.01%
Diadema Partners LP60,000$1.22M1.38%
Engineers Gate Manager LP53,358$1.09M0.02%
MAI Capital Management46,526$948.2K0.01%
Fox Run Management, L.L.C.38,668$788.1K0.14%
Campbell & CO Investment Adviser LLC37,685$768.0K0.06%
Police & Firemen's Retirement System of New Jersey26,479$539.6K0.01%
Raymond James Financial Inc26,143$532.8K0.00%
KLP Kapitalforvaltning AS26,100$531.9K0.00%
Walleye Capital LLC24,820$505.8K0.00%
Verition Fund Management LLC22,601$460.6K0.00%
Pathstone Holdings, LLC21,224$432.5K0.00%
Bryce Point Capital, LLC20,550$418.8K0.12%
Caption Management, LLC19,900$405.6K0.02%
Empowered Funds, LLC18,587$378.8K0.01%
XTX Topco Ltd16,087$327.9K0.03%
Aquatic Capital Management LLC15,694$319.8K0.01%
Two Sigma Advisers, LP15,100$307.7K0.00%
Dark Forest Capital Management LP12,888$262.7K0.04%
CIBC World Markets Corp11,633$237.1K0.00%
Point72 Hong Kong Ltd3,175$64.7K0.00%
GF Fund Management Co. Ltd.3,022$61.6K0.00%
R Squared Ltd580$11.8K0.01%
Caitong International Asset Management Co., Ltd560$11.4K0.01%
Skopos Labs, Inc.172$3.51K0.00%
Sherman Asset Management, Inc.94$1.92K0.00%
Amundi85$1.81K0.00%
Vista Private Wealth Partners. LLC80$1.63K0.00%
Steward Partners Investment Advisory, LLC25$5100.00%
Cassady Schiller Wealth Management, LLC18$3670.00%
Hexagon Capital Partners LLC12$2450.00%
Allworth Financial LP10$2340.00%
WealthTrak Capital Management LLC10$2040.00%
SBI Securities Co., Ltd.5$1020.00%
Global Financial Private Client, LLC2$410.00%
IFP Advisors, Inc1$200.00%
Sandy Spring Bank0$100.00%

Sold out (32)

Institutions that held Denali Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (2)

Institutions that held Denali Therapeutics Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DNLI in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Concentric Wealth Management, LLC46,526$1.36M
ClariVest Asset Management LLC22,964$533.2K